section name header

Table 23-2

Statin Benefit Groups

  • Clinical evidence of ASCVD

  • LDL-C >190 mg/dL

  • Age 40-75 years with diabetes and an LDL-C 70-189 mg/dL

  • Age 40-75 years without diabetes, an LDL-C 70-189 mg/dL, and an estimated 10-year risk of ASCVD >7.5% (10-year risk of ASCVD based on Pooled Cohort Equations available at my.americanheart.org/cvriskcalculator)

Adapted from Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;63(25, pt B):2889-2934.